Quantitative pre- and post-session survey results. by Caterina Zagona-Prizio (14833699)

Published cricothyrotomy training programs using human cadavers: Characteristics and data. by Caterina Zagona-Prizio (14833699)

Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study by Yongxiang Zhang (31421)

“…In this investigation, the ignition delay times (IDTs) of NH₃/<i>n</i>C₁₆H₃₄ mixtures were measured in a rapid compression machine at different NH₃ energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”

Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study by Yongxiang Zhang (31421)

“…In this investigation, the ignition delay times (IDTs) of NH₃/<i>n</i>C₁₆H₃₄ mixtures were measured in a rapid compression machine at different NH₃ energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”

Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study by Yongxiang Zhang (31421)

“…In this investigation, the ignition delay times (IDTs) of NH₃/<i>n</i>C₁₆H₃₄ mixtures were measured in a rapid compression machine at different NH₃ energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”

Exploring the Interaction Chemistry of Ammonia with <i>n</i>‑Hexadecane over Wide Pressure Ranges: An Experimental and Kinetic Modeling Study by Yongxiang Zhang (31421)

“…In this investigation, the ignition delay times (IDTs) of NH₃/<i>n</i>C₁₆H₃₄ mixtures were measured in a rapid compression machine at different NH₃ energy ratios (50%, 70%, and 90%), temperatures of 693–1047 K, pressures of 20–60 bar, and equivalence ratios of 0.5–1.0. …”

Pre- and post-training confidence and anxiety levels based on participants’ level of training. by Caterina Zagona-Prizio (14833699)

Vena cava compression during prone position (top images). by Laura Ormesher (17131361)

Illustration of the progression of COVID-19 over a 100 day time period. by Mackenzie Dalton (14093874)

Effect of different treatments on ionic contents like sodium, calcium, potassium, phosphorous and soluble proteins constituents of two wheat genotypes (Markaz 19 and Ujala 16) afte... by Nida Mansoora (11648641)

Fetal heart rate indices and behavioural state assessment showing the mean values for baseline heart rate and variability and the proportion of cases in each fetal behavioural stat... by Laura Ormesher (17131361)

Response kinetics and relationship to Weber’s law in the m7 controller (Fig 5). by Jonas V. Grini (15374504)

“…<p>The set-point of <i>A</i> is 3.0. (a) Step-wise increase of <i>k</i>₁ from 1.0 to 5.0 at time <i>t</i>=100 at different and constant background perturbations <i>k</i>₃ (0–128.0, applied in phases 1 and 2). …”

Thymol and its combination with classical anthelmintics. by Guillermina Hernando (553795)

Cooperative binding of Isw1a to DNA. by Anne De Cian (6592)

“…At 0.7 pN (trace (3)), while the length of the DNA bound to bead 2 is unchanged (except for a quick transient decrease at ∼430 sec blown up in the inset), the DNA anchored to bead 1 exhibits a rapid decrease in extension. …”

Participants with virologic suppression or failure at week 24. by Tosi M. Mwakyandile (16408705)

Socio-demographic and clinical characteristics of HIV-infected treatment-naïve individuals initiating ART. by Tosi M. Mwakyandile (16408705)

Consolidated Standards of Reporting Trials flow diagram for participants in the trial. by Tosi M. Mwakyandile (16408705)

Changes in baseline CD4 count through week 12 and week 24 according to the linear regression model. by Tosi M. Mwakyandile (16408705)

Most frequently experienced adverse events among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)

Cumulative incidence of mortality and loss to follow-up (LTF) among study participants by treatment arms from baseline through week 24. by Tosi M. Mwakyandile (16408705)